Loading clinical trials...
Loading clinical trials...
Open-Label Prospective Trial Evaluating the Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities
Conditions
Interventions
Ethyol (Amifostine)
Locations
1
United States
The Dale & Frances Hughes Cancer Center
East Stroudsburg, Pennsylvania, United States
Start Date
June 1, 2003
Completion Date
September 1, 2004
Last Updated
September 27, 2005
NCT07190248
NCT07486219
NCT06305754
NCT07336732
NCT06498635
NCT07485114
Lead Sponsor
The Dale & Frances Hughes Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions